Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Canaccord Genuity Downgrades GreenLight Biosciences to Hold, Lowers Price Target to $0.3

Author: Benzinga Newsdesk | May 31, 2023 08:28am
Canaccord Genuity analyst Bobby Burleson downgrades GreenLight Biosciences (NASDAQ:GRNA) from Buy to Hold and lowers the price target from $4 to $0.3.

Posted In: GRNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist